Lupin Ltd will set up a Rs 100-million plant for manufacturing Lovastatin, a cholesterol lowering active pharmaceutical ingredient, at the company's facilities in Tarapur, Maharashtra. The plant, being built to meet USFDA standards, has an initial capacity of above 12 metric tonnes per annum.
Lupin already entered into a contract with a pharmaceutical firm for the supply of Lovastatin API.
The total global market size for Lovastatin and Simvastatin, which is derived from Lovastatin, is above $6 billion.
BSE Code: 500257
© 2026